Eiger files for bankruptcy and will wind down operations after years of setbacks

Eiger BioPharmaceuticals said Monday morning that it filed for Chapter 11 protection in the United States Bankruptcy Court for the Northern District of Texas.

The Palo Alto, CA-based biotech also said Sentynl Therapeutics has inked a “stalking horse” agreement for its approved drug Zokinvy. If the court allows it, Sentynl could pay up to $26 million for the treatment. The drug was approved in 2020 for Hutchinson-Gilford progeria syndrome, an ultra-rare disease in which children age prematurely and have a short life expectancy of about 14 years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Combined marijuana and cigarette smoking may increase lung damage

Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs, according to research being presented today at the annual

November 28, 2023

MarketingRx roundup: Viatris debuts new campaign in Times Square; AstraZeneca renews natural gas deal

Viatris debuted its new corporate campaign last week on the Nasdaq tower in New York City’s Times Square. The tagline is “Everywhere Health Matters,” and

November 15, 2023

Researchers identify crucial risk factors for cognitive decline after stroke

Study identifies key risk factors for post-stroke cognitive impairment and dementia, emphasizing the importance of early detection and management of these conditions.

December 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.